Money and Molecules: Early-Stage Life Science Financing

Early-stage life science companies face a complex and challenging financing environment; even for the virtual life science startups of today, the cost to bring a candidate molecule even to clinical trials is daunting. Yet the number of traditional venture capital firms investing in life sciences has continued to shrink.